Bio Path is engaged in the business of financing and commercializing novel cancer therapeutics acquired from MD Anderson Cancer Center. Currently in Phase human trial.
Quote | Bio-Path Holdings Inc. (NASDAQ:BPTH)
Last: | $1.86 |
---|---|
Change Percent: | 2.58% |
Open: | $1.89 |
Close: | $1.86 |
High: | $1.945 |
Low: | $1.85 |
Volume: | 53,044 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | Bio-Path Holdings Inc. (NASDAQ:BPTH)
2024-06-17 10:10:00 ET June 17, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the first of a two-part series looking at developments for the treatment of blood cancers. Today's snapshot focuses in on acute myeloid leukemia (AML) and the compan...
2024-06-17 09:45:40 ET Palm Beach, FL – June 17, 2024 – According to a report from Mordor Intelligence the Acute Myeloid Leukemia Market size is estimated at USD 1.83 billion in 2024, and is expected to reach USD 2.97 billion by 2029, growing at a CAGR of 10.15% during the...
Message Board Posts | Bio-Path Holdings Inc. (NASDAQ:BPTH)
Subject | By | Source | When |
---|---|---|---|
znewcar1: ML1.27 YH2.28 back under Feb? $BPTH | znewcar1 | investorshangout | 01/27/2023 6:37:54 PM |
znewcar1: ML3.55 LOD3.57 Don't think $3 will hold | znewcar1 | investorshangout | 09/16/2022 7:05:58 PM |
whytestocks: $BPTH News Article - Bio-Path Holdings to Announce Second Quarter 2022 Financial Result | whytestocks | investorshangout | 08/09/2022 11:00:54 PM |
Anyway, pps has been climbing slowly & steadily | cfoofme | investorshub | 07/09/2022 6:57:47 PM |
Anyone here still holding BPTH? | cfoofme | investorshub | 07/08/2022 11:30:11 PM |
News, Short Squeeze, Breakout and More Instantly...
Bio-Path Holdings Inc. Company Name:
BPTH Stock Symbol:
NASDAQ Market:
Bio-Path Holdings Inc. Website:
2024-06-17 10:10:00 ET June 17, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the first of a two-part series looking at developments for the treatment of blood cancers. Today's snapshot focuses in on acute myeloid leukemia (AML) and the compan...